ArticleSovremennye tekhnologii v meditsine2026
Diagnostic Potential of New Systemic Inflammation Markers (MLR, SIRI, CAR, dNLR, ALB/dNLR) in Predicting the Severity of Pathogenic Signs of Rheumatoid Arthritis.
Article in Sovremennye tekhnologii v meditsine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Materials and Methods: An autoimmune RA model (experimental groups) was induced by subcutaneous injection of complete Freund's adjuvant into the right hind limbs of 8-month-old male rats of strains with high (HR/SmY) and low (LR/SmY) resistance to hypoxia. Rats in the control groups received only the solvent. After 35 days, blood was collected from the hearts of all the rats. To calculate the new inflammation biomarkers - CAR, ALB/dNLR, SIRI, dNLR, NC/LC, and MLR - the following laboratory parameters were used: ALB (albumin), CRP (C-reactive protein), MC (monocytes), LC (lymphocytes), and NC (neutrophils). The effectiveness of disease severity assessment using these biomarkers was determined based on histological examination of plantar sections of the tarsal and metatarsophalangeal joints of control and experimental rats. Results: Genetically determined resistance to hypoxia is an important factor in the onset of the pathogenetic RA mechanisms. Low hypoxia resistance was associated with more severe connective tissue pathology compared to high resistance: LR/HR - 164 points/113 points, p≤0.05. The severity of pathomorphological RA changes (considering the organism's resistance to hypoxia), identified histologically (cartilage degeneration: LR/HR - 29 points/18 points, p≤0.01; general joint inflammation: LR/HR - 37 points/26 points, p≤0.01; osteolysis: LR/HR - 6 points/0 points, p≤0.01), was most effectively reflected by the following integral inflammation indices: CAR (LR/HR - 11.55·10 Conclusion: The severity of pathomorphological RA signs depends on genetically determined resistance to hypoxia. For effective prediction of the disease, risk of complications, and treatment efficacy, it is advisable to use the new systemic inflammation biomarkers CAR, ALB/dNLR, and SIRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.